Sublimity Therapeutics
Vincenzo Aversa is a highly experienced Senior Formulation Scientist and IP Technical Associate, currently contributing to Sublimity Therapeutics since June 2018 and Sigmoid Pharma since June 2017. Previously, Vincenzo held the position of Formulation Scientist at Sigmoid Pharma from June 2007 to January 2009. Vincenzo earned a Doctor of Philosophy (PhD) in Biopharmaceutics and Pharmacokinetics from Università degli Studi di Parma (2004-2007) and completed a degree in chimica e tecnologia farmaceutiche at Università della Calabria (1996-2004).
This person is not in any teams
This person is not in any offices
Sublimity Therapeutics
Sublimity Therapeutics Limited (Sigmoid Pharma Limited), a specialty pharmaceutical company focused on the treatment of ulcerative colitis.